Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat

被引:35
|
作者
Tang, Justin I. [1 ]
Kenyon, Chris J. [1 ]
Seckl, Jonathan R. [1 ]
Nyirenda, Moffat J. [1 ]
机构
[1] Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Endocrinol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland
关键词
11 beta-hydroxysteroid dehydrogenase type 2; fetal programming; glucocorticoids; hypertension; salt sensitivity; APPARENT MINERALOCORTICOID EXCESS; CORTISOL-CORTISONE SHUTTLE; BLOOD-PRESSURE; MOLECULAR MECHANISMS; ADULT DISEASE; RECEPTOR; GROWTH; EXPOSURE; LICORICE; FETAL;
D O I
10.1097/HJH.0b013e328340aa18
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Prenatal glucocorticoid excess programs hypertension in adulthood. The underlying mechanisms are unknown. Here, we tested whether hypertension in this model is due to increased renal mineralocorticoid activity. Methods Pregnant rats were injected daily with the synthetic glucocorticoid dexamethasone (DEX) or vehicle during the last week of pregnancy. Blood pressure, electrolytes and target gene expression were measured in the offspring. Results Adult DEX-treated offspring were hypertensive (SBP, 140.1 +/- 2.4 vs. 128.6 +/- 3.2 mmHg; P=0.009), hypokalemic (4.5 +/- 0.2 vs. 5.1 +/- 0.2 mmol/l; P=0.03) and had suppressed plasma renin concentration (23.6 +/- 4.8 vs. 43.8 +/- 5.9 ng/ml; P=0.017). DEX programming had similar effects in younger rats (age 2 months), but only when fed a high-salt diet. Although these data are consistent with excess mineralocorticoid activity, plasma aldosterone levels were unaffected and daily urinary aldosterone values were decreased (136.1 +/- 27.0 vs. 303.6 +/- 47.0 ng/kg; P=0.008). Accordingly, we assessed renal factors that might influence mineralocorticoid responsiveness. Renal expression of mineralocorticoid receptor and glucocorticoid receptor mRNAs was unaltered, as was 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) which regenerates active glucocorticoids. However, renal mRNA for 11 beta-HSD2, which catalyses inactivation of glucocorticoids in the distal nephron and thus protects mineralocorticoids from glucocorticoids, was decreased by 45% in both new born and adult rats (P<0.01). The functional significance of this reduction was confirmed by measurements of renal 11 beta-HSD activity and by demonstrating that the mineralocorticoid properties of cortisol were enhanced in DEX-programmed rats. Additionally, the difference in blood pressure between DEX and control groups was abolished upon administration of spironolactone, a mineralocorticoid receptor antagonist. Conclusion The blood pressure phenotype of DEX-programmed rats may in part be explained by a life-long reduction in renal 11 beta-HSD2 activity. Salt-sensitive hypertension could be programmed by prenatal stress. J Hypertens 29:282-289 (C) 2011 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 50 条
  • [11] EFFECTS OF EMPAGLIFLOZIN ON SALT-SENSITIVE HYPERTENSION AND RENAL INFLAMMATION IN RAT
    Kim, G. H.
    Jo, C. H.
    Kim, S.
    JOURNAL OF HYPERTENSION, 2018, 36 : E76 - E76
  • [12] Hypertension and renal abnormalities caused by targeted inactivation of 11β hydroxysteroid dehydrogenase type 2
    Fleming, S
    Kotelevtsev, YV
    Brown, RW
    Edwards, CRW
    Seckl, JR
    Mullins, JJ
    JOURNAL OF PATHOLOGY, 1999, 187 : 11A - 11A
  • [13] Effect of 3β-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat
    Gomez-Sanchez, EP
    Samuel, J
    Vergara, G
    Ahmad, N
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 288 (02) : R389 - R393
  • [14] Salt sensitivity and 11β-hydroxysteroid dehydrogenase type 2 activity
    Kerstens, MN
    Navis, G
    Dullaart, RPF
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (03) : 283 - 284
  • [15] Expression of renal 11β-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function
    Quinkler, M
    Zehnder, D
    Lepenies, J
    Petrelli, MD
    Moore, JS
    Hughes, SV
    Cockwell, P
    Hewison, M
    Stewart, PM
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (02) : 291 - 299
  • [16] Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
    Kotelevtsev, Y
    Brown, RW
    Fleming, S
    Kenyon, C
    Edwards, CRW
    Seckl, JR
    Mullins, AJ
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05): : 683 - 689
  • [17] The role of the 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
    Ferrari, P
    Lovati, E
    Frey, FJ
    JOURNAL OF HYPERTENSION, 2000, 18 (03) : 241 - 248
  • [18] The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
    Ferrari, Paolo
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (12): : 1178 - 1187
  • [19] Glucocorticoids stimulate the expression of 11β-hydroxysteroid dehydrogenase type 2 in cultured human placental trophoblast cells
    van Beek, JP
    Guan, HY
    Julan, L
    Yang, KP
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5614 - 5621
  • [20] Regulation of 11 beta-hydroxysteroid dehydrogenase-2 (11 beta HSD-2) in the kidney of the salt-sensitive (S) and salt-resistant (R) DAHL rat.
    FrancoSaenz, R
    Shen, P
    Lee, SJ
    Cicila, GT
    Henrich, WL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1368 - A1368